Further studies need to validate these findings and investigate the feasibility of conducting specific nutritional or medical interventions on the concentrations of FABP4 to improve insulin sensitivity and reduce GDM risk during early pregnancy. The gene discussed is FABP4; the disease is gestational diabetes.